Chase Investment Counsel Corp Amerisourcebergen Corp Transaction History

Chase Investment Counsel Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$148.37 - $168.96 $1.42 Million - $1.61 Million	-9,537 Reduced 88.01%	1,299 $207,000
Q4 2022 Jan 25, 2023	SELL	$137.35 - $173.99 $498,992 - $632,105	-3,633 Reduced 25.11%	10,836 $1.8 Million
Q3 2022 Oct 31, 2022	SELL	$135.33 - $152.66 $429,672 - $484,695	-3,175 Reduced 17.99%	14,469 $1.96 Million
Q2 2022 Jul 26, 2022	BUY	$140.68 - $165.73 $1.75 Million - $2.06 Million	12,428 Added 238.27%	17,644 $2.5 Million
Q1 2022 Apr 21, 2022	BUY	$130.45 - $155.14 $680,427 - $809,210	5,216 New	5,216 $806,000

1,263

168M

7.52M

6.12M

Ticker ABC
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 207,258,000
Market Cap $38.4B
Description
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, inc...

Get notified when there are updates to the investment portfolio of Chase Investment Counsel Corp, based on Form 13F filings with the SEC.

Stay updated on Chase Investment Counsel Corp with notifications on news.